NewsBenzinga康特菲茨杰拉德维持对Celldex Therapeutics的超额持有评级，将目标股价提高至72美元 康特菲茨杰拉德维持对Celldex Therapeutics的超额持有评级，将目标股价提高至72美元 Benzinga 2026.09.22 15:33 (GMT+0) Open on Benzinga Other news 2 Strong Buy Trending Stocks with Double-Digit Upside: CIEN and JHX - TipRanks.com Costco Stock (COST): Evercore Backs Retail Giant Ahead of Q4 Earnings — Here’s What It Expects - TipRanks.com Why Shopify Stock, Twilio Are Rising On Meta's Muse Rollout Berkshire Hathaway Raises Stake In This Ramshackle Homebuilder Meta Tests Human Support for Muse AI Agent as Privacy Concerns Raise Investor Questions - TipRanks.com Piper Sandler Maintains Neutral on SoundHound AI, Lowers Price Target to $6
Costco Stock (COST): Evercore Backs Retail Giant Ahead of Q4 Earnings — Here’s What It Expects - TipRanks.com
Meta Tests Human Support for Muse AI Agent as Privacy Concerns Raise Investor Questions - TipRanks.com
